What does Dr. Tim Wessels – Algemene Medische Oncologie do?

Dr. Tim Wessels – Algemene Medische Oncologie is a specialist medical practice in Holsbeek. Private Limited, started on 5 July 2020, 1 establishment.

What is the address of Dr. Tim Wessels – Algemene Medische Oncologie?

The registered office of Dr. Tim Wessels – Algemene Medische Oncologie is located at Sint-Geertruibos 23, 3220 Holsbeek.

Is Dr. Tim Wessels – Algemene Medische Oncologie still active?

Yes. According to the CBE (17 September 2026) Dr. Tim Wessels – Algemene Medische Oncologie is active, legal situation “Normale toestand”, started on 5 July 2020.

Is Dr. Tim Wessels – Algemene Medische Oncologie registered on Peppol?

Yes, Dr. Tim Wessels – Algemene Medische Oncologie is registered on the Peppol network with ID 0208:0749800694.

What is the enterprise number of Dr. Tim Wessels – Algemene Medische Oncologie?

The enterprise number of Dr. Tim Wessels – Algemene Medische Oncologie is BE0749800694.

When was Dr. Tim Wessels – Algemene Medische Oncologie founded?

Dr. Tim Wessels – Algemene Medische Oncologie was founded on 5 July 2020.

Is Dr. Tim Wessels – Algemene Medische Oncologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 July 2020; 4 annual accounts filed, latest fiscal year 2024.

How much profit did Dr. Tim Wessels – Algemene Medische Oncologie make in 2024?

Dr. Tim Wessels – Algemene Medische Oncologie posted a profit after taxes of € 198,988 in financial year 2024.

What is the revenue of Dr. Tim Wessels – Algemene Medische Oncologie?

As a small company, Dr. Tim Wessels – Algemene Medische Oncologie is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 271,643.

Dr. Tim Wessels – Algemene Medische Oncologie (Private Limited)

Dossier Dr. Tim Wessels – Algemene Medische Oncologie, printed on 17 September 2026 from databakkes.be/en/0749800694/dr-tim-wessels-algemene-medische-oncologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

Dr. Tim Wessels – Algemene Medische Oncologie from Holsbeek, company number BE0749800694, closed financial year 2024 with a result of € 198,988 after tax. For that financial year Dr. Tim Wessels – Algemene Medische Oncologie recorded a gross margin of € 271,643 and equity of € 12,466. Compared with financial year 2023, the result moved from € 144,595 to € 198,988. Profitable, and profit is growing. The buffer shrank hard: equity is 96 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on May 7, 2025.

What it is worth Shrank hard

€ 12,466

▼ 96% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 198,988

▲ 38% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 204,224

▼ 41% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 492,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2024

Vehicles and equipment

€ 5,859

▲ 87% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,016

▼ 1% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 25,367

▼ 42% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Revenue	€ 216,774 Revenue 2021: € 216,774 First fiscal year in the series	-	-	-
Gross margin	€ 86,234 Gross margin 2021: € 86,234 First fiscal year in the series	€ 119,454 Gross margin 2022: € 119,454 ▲ 39% vs 2021 (€ 86,234) Favourable step	€ 189,012 Gross margin 2023: € 189,012 ▲ 58% vs 2022 (€ 119,454) Favourable step	€ 271,643 Gross margin 2024: € 271,643 ▲ 44% vs 2023 (€ 189,012) Favourable step	▲ 44%
Profit after taxes	€ 66,936 Profit after taxes 2021: € 66,936 First fiscal year in the series	€ 90,947 Profit after taxes 2022: € 90,947 ▲ 36% vs 2021 (€ 66,936) Favourable step	€ 144,595 Profit after taxes 2023: € 144,595 ▲ 59% vs 2022 (€ 90,947) Favourable step	€ 198,988 Profit after taxes 2024: € 198,988 ▲ 38% vs 2023 (€ 144,595) Favourable step	▲ 38%
Equity	€ 69,936 Equity 2021: € 69,936 First fiscal year in the series	€ 160,882 Equity 2022: € 160,882 ▲ 130% vs 2021 (€ 69,936) Favourable step	€ 305,478 Equity 2023: € 305,478 ▲ 90% vs 2022 (€ 160,882) Favourable step	€ 12,466 Equity 2024: € 12,466 ▼ 96% vs 2023 (€ 305,478) Unfavourable step	▼ 96%
Total debts	€ 20,870 Total debts 2021: € 20,870 First fiscal year in the series	€ 45,098 Total debts 2022: € 45,098 ▲ 116% vs 2021 (€ 20,870) Unfavourable step	€ 45,518 Total debts 2023: € 45,518 ▲ 1% vs 2022 (€ 45,098) Unfavourable step	€ 217,383 Total debts 2024: € 217,383 ▲ € 171,865 vs 2023 (€ 45,518) Unfavourable step	▲ € 171,865
Cash	€ 84,537 Cash 2021: € 84,537 First fiscal year in the series	€ 203,686 Cash 2022: € 203,686 ▲ 141% vs 2021 (€ 84,537) Favourable step	€ 345,594 Cash 2023: € 345,594 ▲ 70% vs 2022 (€ 203,686) Favourable step	€ 204,224 Cash 2024: € 204,224 ▼ 41% vs 2023 (€ 345,594) Unfavourable step	▼ 41%
Land & buildings	-	-	-	€ 2,537 Land & buildings 2024: € 2,537 First fiscal year in the series
Retained profit	€ 66,936 Retained profit 2021: € 66,936 First fiscal year in the series	€ 157,882 Retained profit 2022: € 157,882 ▲ 136% vs 2021 (€ 66,936) Favourable step	€ 302,478 Retained profit 2023: € 302,478 ▲ 92% vs 2022 (€ 157,882) Favourable step	€ 9,466 Retained profit 2024: € 9,466 ▼ 97% vs 2023 (€ 302,478) Unfavourable step	▼ 97%
Dividend	€ 0 Dividend 2021: € 0 First fiscal year in the series	€ 0 Dividend 2022: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 492,000 Dividend 2024: € 492,000 Unchanged (€ 0) Unchanged
Balance sheet total	€ 90,806 Balance sheet total 2021: € 90,806 First fiscal year in the series	€ 205,980 Balance sheet total 2022: € 205,980 ▲ 127% vs 2021 (€ 90,806) Unchanged	€ 350,996 Balance sheet total 2023: € 350,996 ▲ 70% vs 2022 (€ 205,980) Unchanged	€ 229,849 Balance sheet total 2024: € 229,849 ▼ 35% vs 2023 (€ 350,996) Unchanged	▼ 35%

Key figures of Dr. Tim Wessels – Algemene Medische Oncologie, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to Dr. Tim Wessels – Algemene Medische Oncologie?

What happened at Dr. Tim Wessels – Algemene Medische Oncologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 7, 2025 New annual accounts for financial year 2024: profit of € 198,988 (▲ 38% vs 2023). Source: NBB ↗
Jul 5, 2020 New establishment in Holsbeek. KBO
Jul 5, 2020 Start of the company according to the CBE. KBO

In short

From € 66,936 profit in 2021 to € 198,988 profit in 2024.

Paid € 158,193 in corporate taxes since 2021.

Best year ever: 2024, with € 198,988 profit.

Paid out € 492,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Tim Wessels – Algemene Medische Oncologie? We notify you, reason included.

Follow Dr. Tim Wessels – Algemene Medische Oncologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Establishments

Establishment units

Physical locations of this company

Registered office

Sint-Geertruibos 23

3220 Holsbeek

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0749.800.694
VAT number: BE 0749.800.694
Registered office: Sint-Geertruibos 23, 3220 Holsbeek
Names & denominations: Dr. Tim Wessels – Algemene Medische Oncologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 5 July 2020
Peppol: Active · Active since 16 Jan 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗

Dr. Tim Wessels – Algemene Medische Oncologie